EWA
GMAB icon

EverSource Wealth Advisors’s Genmab GMAB Stock Holding History

EverSource Wealth Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123K Buy
4,597
+1,565
+52% +$46.9K ﹤0.01% 1307
2025
Q4 		$93.4K Buy
3,032
+854
+39% +$26.6K ﹤0.01% 1356
2025
Q3 		$66.8K Buy
2,178
+64
+3% +$1.56K ﹤0.01% 1492
2025
Q2 		$43.7K Buy
2,114
+1,174
+125% +$24.1K ﹤0.01% 1709
2025
Q1 		$18.4K Sell
940
-317
-25% -$6.65K ﹤0.01% 1733
2024
Q4 		$26.2K Buy
1,257
+939
+295% +$20.6K ﹤0.01% 1487
2024
Q3 		$7.75K Buy
318
+135
+74% +$3.61K ﹤0.01% 2007
2024
Q2 		$5.18K Buy
183
+25
+16% +$709 ﹤0.01% 2213
2024
Q1 		$4.38K Buy
158
+42
+36% +$1.23K ﹤0.01% 2102
2023
Q4 		$3.69K Sell
116
-158
-58% -$4.96K ﹤0.01% 1979
2023
Q3 		$9.66K Buy
274
+10
+4% +$381 ﹤0.01% 1431
2023
Q2 		$10K Sell
264
-148
-36% -$5.9K ﹤0.01% 1436
2023
Q1 		$15.6K Buy
412
+338
+457% +$13K ﹤0.01% 1182
2022
Q4 		$3.14K Buy
74
+22
+42% +$907 ﹤0.01% 1771
2022
Q3 		$2K Buy
+52
New +$1.83K ﹤0.01% 1667
2022
Q2 		– Sell
-288
Closed -$10K – 1776
2022
Q1 		$10K Buy
288
+221
+330% +$7.58K ﹤0.01% 968
2021
Q4 		$3K Buy
+67
New +$2.79K ﹤0.01% 1423

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

EverSource Wealth Advisors's GMAB Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Genmab (GMAB) stake by 52% in Q1 2026, buying an estimated $46.9K and bringing the position to 4,597 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

EverSource Wealth Advisors first reported a position in GMAB in Q4 2021 and has held it in 17 quarters since. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • EverSource Wealth Advisors held 4,597 shares of Genmab worth $123K as of Q1 2026.
  • EverSource Wealth Advisors bought 1,565 Genmab shares in Q1 2026, an estimated $46.9K.
  • Genmab made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #1307 holding.
  • EverSource Wealth Advisors first reported a position in Genmab in Q4 2021 and has held it in 17 quarters since.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.